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Background
Recent studies linking immune signatures in cancer with
prognosis have provided unequivocal proof of the essen-
tial role of the immune system in tumor pathophysiology.
They have also initiated a quest for immune biomarkers
that could serve as intermediate endpoints of response to
therapy and outcome in cancer. In view of growing evi-
dence for interplay between tumor and systemic circula-
tion, it is critically important to define relationships
between the tumor and the periphery in order to reveal
novel prognostic and/or predictive biomarkers for cancer.
Methods
Herein, we correlated density and localization of tumor
infiltrating immune cells with levels of circulating cyto-
kines/chemokines and mi-RNAs in breast cancer (BCa)
patients with invasive ductal carcinoma without neoadju-
vant therapy. To this end, fifty BCa patients were enrolled
with written informed consent. Serum was obtained from
patients one day before surgery and compared with nor-
mal donors. The analysis of immune cell infiltrates (CD4+,
CD8+, FoxP3+ and CD163+) was performed by IHC in
paraffin-embedded tissues. The density (i.e. the number of
positive cells per mm2 tissue surface area) and the relative
ratios among the different subpopulations, in the tumor
center and the invasive front, were analyzed. As indicators
of peripheral immunity several cytokines/chemokines (i.e.
ΤGF-b1, ΙL-1Ra, IL-9, IL-10, RANTES) were determined
in patient serum using LUMINEX® platform technology.
The levels of circulating mi-RNAs (miR-21, miR-23a,
miR-146a) were estimated by qRT-PCR.
Results
Significant correlations among cytokines/chemokines or
mi-RNAs in sera were detected among patients but not
in healthy donors. There were also correlations between
several cytokines/chemokines and/or mi-RNAs with the
density and location of different immune-cell subpopu-
lations intra-tumorally. Importantly, we also established
correlations between the relative distribution of different
immune cell subpopulations within the tumor and spe-
cific circulating factors. Thus, we observed a direct cor-
relation between circulating RANTES and CD4/CD8
ratio in the tumor center, whereas at the same time
RANTES negatively correlated with the CD4/CD163
ratio at the invasive front.
Conclusions
Our results show for the first time that the differential
distribution of immune-cell subpopulations in the
tumor microenvironment as well as their ratios are asso-
ciated with a functional indication in the periphery
which is reflected in a significant relationship with dif-
ferent systemic immune profiles. We believe that these
local and systemic immune signatures either alone or in
combination may represent more sensitive biomarkers
for the clinical outcome of BCa patients. However, their
prognostic and/or predictive significance remains to be
evaluated in the clinical setting.
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